The investment narrative surrounding Hims & Hers Health, Inc. presents a complex puzzle. On one hand, institutional money is flowing in and the company i ...

The fear gauge CBOE Volatility Index (VIX) decreased 5.8% to 14.85. A total of 17.05 billion shares were traded on Thursday, ...

Analysts are largely maintaining a "Hold" stance for now. The consensus average price target of $44.90 implies potential upside, but experts appear to be taking a wait-and-see approach. The key ...

Detailed price information for Soundhound Ai Inc Cl A (SOUN-Q) from The Globe and Mail including charting and trades.

Goldman Sachs Group Inc, SPDR® S&P 500® ETF Trust, MGM Resorts International, International Business Machines. Read 's Market Analysis on Investing.com ...

The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...

Hims reports that 70% of Americans believe an economic downturn encourages healthier habits, like cooking at home and ...

Delving into the details, we found 53% of traders were bullish, while 30% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $373,316, and 7 were calls, valued ...

In a strategic pivot, the company has launched its weight-loss program in the United Kingdom. There, Hims & Hers is offering legitimate, branded medications—Novo Nordisk's Wegovy and Eli Lilly's ...

Hims Hers Health Inc (NYSE:HIMS) stock fell 4.4% Wednesday after U.S. lawmakers introduced legislation that could significantly impact the company’s fastest-growing product category.

Against this backdrop, short sellers continued to concentrate on consumer names worldwide--particularly across EMEA--while Software & Services also drew significant U.S. short-selling activity, ...

Here's a look at the top 10 most shorted stocks in the market right now, including Lucid, MARA, Kohl's and more.